We are experts and believe that the field of diagnostics is changing with testing increasingly moving away from traditional lab-based testing alone.
We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the ability of decision makers to deploy a more rapid response to results.
We at Abingdon Health are committed and honest in all that we do. We value the quality and contribution of all, priding ourselves on building long-lasting and trusting partnerships – because by working transparently with customers, partners and colleagues, we are better together. With an exceptional pedigree in developing and manufacturing rapid tests Abingdon Health are expert in responding to our customers varied needs with specific and customisable solutions.
Our mission: To improve life by making rapid results accessible to all. By providing the best lateral flow rapid test solutions, we believe we can support the increase in access to diagnostics across many industries and locations throughout the world. Faster access to results allows for rapid decision making and solutions. This ability has a significant role to play in improving life in so many ways.
Company’s Keywords:
medical diagnostics, infectious diseases, point of care testing, monoclonal antibodies, rapid tests, animal health, agrifood, lateral flow manufacturing, lateral flow assay development, assay reader systems, smartphone lateral flow reader, mhealth, covid19 rapid tests, igg neutralising antibody tests
<82
<16089000
<2008